ID   LANCEi020-A-4
SY   iPS-16-FBN1-HI1; IPSC16-FBN1-HI1
DR   hPSCreg; LANCEi020-A-4
DR   Wikidata; Q108820660
RX   PubMed=34174776;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 3603; FBN1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR71 ! LaNCE hiPSC-16
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 6
RX   PubMed=34174776; DOI=10.1016/j.scr.2021.102434;
RA   Borsoi J., Farinha-Arcieri L.E., Morato-Marques M., Sarafian R.D.,
RA   Pinheiro M., Pereira L.V.;
RT   "Generation of genetically modified human induced pluripotent stem
RT   cell lines harboring haploin sufficient or dominant negative variants
RT   in the FBN1 gene.";
RL   Stem Cell Res. 54:102434-102434(2021).